New & Noteworthy

March 2022

Difluprednate Ophthalmic Emulsion

Amneal Pharmaceuticals

Amneal Pharmaceuticals announces that it has received Abbreviated New Drug Application (ANDA) approval from the US FDA for difluprednate ophthalmic emulsion 0.05%, which is the generic version of Durezol. The medication is used in the treatment of inflammation and pain associated with ocular surgery.

Request More Information

Current Issue